SHH

In one line: A gene whimsically named "Sonic hedgehog" turns out to be a master architect of the body — a morphogen whose gradient tells each cell where it is; too little of it leaves an embryo with a single eye, too much drives the most common cancer, and the plant toxin that first jammed it pointed the way to a cure.

---

The name

The original hedgehog gene was found in fruit flies in the famous 1980 genetic screen of Christiane Nüsslein-Volhard and Eric Wieschaus (Nobel Prize, 1995): mutant larvae are covered in spike-like denticles, like a hedgehog. When three labs (Ingham, McMahon, Tabin) cloned the vertebrate versions in 1993, two were named after real hedgehog species (Desert, Indian) — and a postdoc in Tabin's lab named the third Sonic hedgehog, after the Sega game. The whimsy has real friction: SHH mutations cause grave disease, and some clinical geneticists wince at delivering such a diagnosis under a cartoon's name.

The gene, and the mechanism

SHH sits at chromosome 7q36.3 and encodes a secreted signalling protein — a morphogen. Released from a small "organizer" region of the embryo (the notochord; the limb's zone of polarizing activity), it spreads outward into a concentration gradient. Each nearby cell measures how much SHH it sees, and that number is a coordinate: it tells the cell where it sits and what to become — which digit of the hand, which class of neuron in the spinal cord. One molecule, drawing the body's map.

Too little: holoprosencephaly

Lose that signal and the map fails at the midline. The forebrain never divides into two hemispheres — a severe malformation called holoprosencephaly, whose spectrum runs from a single central front tooth at the mild end to a single median eye (cyclopia) at the most severe, the latter usually incompatible with life. In 1996, SHH became the first gene tied to holoprosencephaly (Roessler et al.).

Nature's accident: the corn lily

In 1957, lambs in Idaho were born with a single eye. A USDA investigation traced it to a wildflower — the corn lily, Veratrum californicum — and its steroidal-alkaloid toxin, cyclopamine. Cyclopamine binds a protein called Smoothened and shuts the Hedgehog pathway off; pregnant ewes that grazed the plant produced lambs that phenocopied the genetic disease. (Note the careful causal chain: the plant blocks the same signal that SHH mutations lose.)

Too much: cancer — and the cure

Turn the dial the other way and the danger flips. Over-active Hedgehog signalling drives basal cell carcinoma, the most common cancer in the world. And the very target cyclopamine revealed — Smoothened — is where we now strike: vismodegib (Erivedge), approved by the FDA on 30 January 2012, the first medicine to drug the Hedgehog pathway. Cyclopamine revealed the target; vismodegib is a separate, synthetic Smoothened inhibitor — the plant didn't become the drug, it pointed to it.

Sources

Full claim-by-claim evidence is in references.md. Primary anchors:

• SHH gene/locus/morphogen: NCBI GTR 6469 · OMIM 600725
• Naming history: STAT oral history
• SHH → holoprosencephaly: Roessler et al. 1996, PMID 8896572 · OMIM 142945
• Cyclopamine ⊣ Smoothened: Chen et al. 2002, PMC187469 · Cyclopamine
• Vismodegib FDA 2012: FDA approval, PMID 23515405 · StatPearls

Accuracy notes: (1) direction matters — too little SHH → birth defect, too much → cancer; (2) cyclopamine ≠ vismodegib — the toxin revealed the Smoothened target; vismodegib is a separate synthetic SMO inhibitor.